Google DeepMind disbands Nobel-winning AlphaFold team in 2026 pivot

Google DeepMind has dismantled the team behind its Nobel Prize-winning AlphaFold system, reassigning researchers to Gemini-focused projects.

Google DeepMind has disbanded the research group that produced AlphaFold, the AI system that solved biology's 50-year-old protein folding problem and earned the lab its 2024 Nobel Prize in Chemistry, according to a Financial Times report Wednesday. The move reassigns most of the team's key members to projects centered on the Gemini large language model, while roughly a quarter of the group has left the company entirely.

"Google has reassigned most of the team's key members and the original authors of its papers, while a few others have already left the company," the Financial Times reported, citing people familiar with the restructuring. The shakeup reflects a broader strategic shift at DeepMind away from dedicated scientific research teams toward building general-purpose AI systems that can assist across multiple scientific domains.

The AlphaFold team's dissolution comes with notable departures. John Jumper, who shared the 2024 Nobel Prize in Chemistry with DeepMind CEO Demis Hassabis for his work leading AlphaFold, left the company in June for Anthropic after nearly nine years. Two other AlphaFold authors — Jonas Adler and Alexander Pritzel, both of whom also contributed to Gemini — followed Jumper to Anthropic, Bloomberg reported. Other former staff members were reassigned to Isomorphic Labs, Alphabet's drug-discovery spin-off that builds on AlphaFold's technology.

The Gemini-first strategy

The restructuring represents Google's decision to concentrate resources on Gemini, its flagship AI model competing with OpenAI's GPT and Anthropic's Claude. Pushmeet Kohli, vice president of research at Google DeepMind, told the Financial Times that the lab's strategy has evolved from focusing on individual grand challenges toward broader AI capabilities. "Our strategy over the last nine years has been to focus on grand challenges... a concrete goal every project is focused on," Kohli said. "The strategy has evolved."

The shift carries risks. AlphaFold was DeepMind's most tangible scientific achievement — a system that predicted over 200 million protein structures and attracted more than 3 million users across 190 countries. The Nobel committee credited AlphaFold2 with helping researchers understand antibiotic resistance and create enzymes capable of decomposing plastic. Disbanding the team that delivered that credibility in the same period that key talent migrates to Anthropic raises questions about Google's ability to retain top AI researchers.

What it means for investors

For Alphabet investors, the restructuring signals a bet that general-purpose AI models will ultimately generate more value than specialized scientific tools. DeepMind's new direction envisions Gemini-powered systems that can assist scientists across biology, chemistry and physics — potentially automating parts of research that currently require dedicated teams. But the near-term cost is visible: the loss of Jumper, Adler and Pritzel to Anthropic, and the departure of Noam Shazeer — a Gemini co-lead and co-author of the foundational 2017 Transformer paper — to OpenAI, contributed to a roughly 5% decline in Alphabet shares in late June, according to Bloomberg.

Anthropic now holds three AlphaFold veterans with direct experience building AI systems that millions of researchers trust. If Anthropic applies that expertise to scientific applications within Claude, it could narrow Google's lead in AI-driven drug discovery and materials science — areas where DeepMind had established a clear advantage. Alphabet shares, trading at roughly 22 times forward earnings, face the added challenge of proving that breaking up its most celebrated science team was a strategic necessity rather than a misstep.

This article is for informational purposes only and does not constitute investment advice.